Efficacy of Indapamide SR Compared With Enalapril in Elderly Hypertensive Patients With Type 2 Diabetes
Author(s) -
J PUIG,
Michel Marre,
F Kokot,
Mariana F. Fernández,
G Jermendy,
Lionel H. Opie,
Valentin Moyseev,
André Scheen,
C Ionescu-Tîrgovişte,
Maria Helena Saldanha
Publication year - 2006
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2006.05.018
Subject(s) - microalbuminuria , indapamide , enalapril , medicine , blood pressure , urology , type 2 diabetes , diabetes mellitus , creatinine , ace inhibitor , endocrinology , essential hypertension , angiotensin converting enzyme
Blood pressure control is the main influential variable in reducing microalbuminuria in patients with type 2 diabetes. In this subanalysis of the Natrilix SR versus Enalapril Study in hypertensive Type 2 diabetics with micrOalbuminuRia (NESTOR) study, we have compared the effectiveness of indapamide sustained release (SR) and enalapril in reducing blood pressure and microalbuminuria in patients > or =65 years of age.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom